IOL Chemicals and Pharmaceuticals has commenced state-of-the-art Unit-11 on March 24, 2025 for manufacturing Paracetamol at its existing location at Barnala, Punjab with an installed capacity of 10,800 MTPA. Unit-11 is supported by backward integration, with in-house production of key intermediates, Para Amino Phenol (PAP) and Acetic Anhydride, both essential for Paracetamol manufacturing.
Further, the company has enhanced the installed capacity of Unit 5 for manufacturing Clopidogrel Bisulphate from 180 MTPA to 240 MTPA on March 24, 2025 with an capital expenditure of Rs 7.87 crore funded through internal accruals.
IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.
